Infex Therapeutics to present new RESP-X Phase IIa data in late-breaking session at ERS Congress 2026
Infex Therapeutics to present new RESP-X Phase IIa data in late-breaking session at ERS Congress 2026 Presentation will provide additional analysis from the Phase IIa study of RESP-X in Pseudomonas